Sichuan Huiyu Pharmaceutical Co., Ltd
Sichuan Huiyu Pharmaceutical Co., Ltd
Explore linked clinical trials.10 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Ferric Derisomaltose Injection in Chinese Participants With Iron Deficiency Anemia Under Fasting Conditions | Anemia, Hypochromic, Hemic and Lymphatic Diseases, Iron Deficiencies, Nutritional and Metabolic Diseases, anemia, hematologic disorder, iron deficiency anemia, iron metabolism disease, metabolic disease | Recruiting | Phase 1 | 2026-08-27 | NCT07790562 | |
| Phase 1/2 Clinical Study of HY07121 for Injection (Subcutaneous) in Patients With Advanced Solid Tumors | Efficacy; Safety; Tolerability | Not yet recruiting | Phase 1 / Phase 2 | 2026-08-27 | NCT07789327 | |
| Bioequivalence Study of Ferric Carboxymaltose Injection in Healthy Chinese Participants Under Fasting Conditions | Healthy Adult | Recruiting | Phase 1 | 2026-05-26 | NCT07606105 | |
| A Phase I/Ⅱ Human Study of HY0001a for Injection in Adult Participants With Advanced Solid Tumors | Solid Tumor | Recruiting | Phase 1 / Phase 2 | 2026-03-09 | NCT07069062 | |
| Bioequivalence Study of Paclitaxel for Injection (Albumin Bound) in Subjects With Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Not applicable | 2026-03-09 | NCT06765590 | |
| A Phase I Study of HY-2003 in the Subjects With Excessive Submental Fat Accumulation | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, follicular lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 1 | 2026-03-09 | NCT06756490 | |
| Phase 1/2 Study of HYP-2090PTSA in Patients With Advanced Solid Tumors Harboring KRAS Mutation | Efficacy; Safety; Tolerability | Recruiting | Phase 1 / Phase 2 | 2026-01-29 | NCT06243354 | |
| Phase 1/2 Clinical Study of HY07121 Powder for Solution for Infusion in Patients With Advanced Solid Tumors | Efficacy; Safety; Tolerability | Recruiting | Phase 1 / Phase 2 | 2026-01-28 | NCT06639256 | |
| A Phase I/II Study of HYP-6589 Monotherapy in Treating Advanced Solid Tumors and in Combination With Tyrosine Kinase Inhibitors in Treating Patients With Advanced NSCLC Positive for Driver Genes | Solid Tumor | Recruiting | Phase 1 / Phase 2 | 2025-12-23 | NCT06712680 | |
| A Phase I/II Study of HY05350 in Mesothelin(MSLN)-Positive Advanced Solid Tumors | Advanced Solid Tumor | Recruiting | Phase 1 / Phase 2 | 2025-11-25 | NCT07083323 |